Despite unveiling a significant capital return program to investors, Altria Group encountered substantial market skepticism as its shares retreated. The tobacco corporation revealed it would double its share repurchase authorization to $2 billion while announcing its 60th dividend increase in 56 years. This display of shareholder commitment, however, failed to prevent a downward trajectory for the stock, raising questions about the underlying challenges confronting the established tobacco enterprise.
Financial Performance Presents Contrasting Picture
The company’s third-quarter 2025 earnings report highlighted several concerning trends. A 3.0% decline in net revenues brought the figure to $6.1 billion, falling short of post-excise tax analyst projections of $5.31 billion. This revenue underperformance was primarily driven by an 8.2% contraction in cigarette shipment volumes.
On a more positive note, Altria’s adjusted earnings per share of $1.45 narrowly surpassed market expectations by one cent. This result also represented a 3.6% improvement over the same period last year. The ongoing share buyback initiative contributed to this earnings beat by reducing the number of shares outstanding.
Should investors sell immediately? Or is it worth buying Altria?
Strategic Challenges in a Transforming Market
Altria’s efforts to navigate the industry’s transformation toward reduced-risk products face significant obstacles. The company recently expanded distribution of its on! PLUS nicotine pouches into Florida, North Carolina, and Texas. However, regulatory constraints continue to hamper progress, with the NJOY ACE e-cigarette product remaining excluded from markets due to an International Trade Commission ruling.
The broader industry context remains challenging, with the overall U.S. cigarette market estimated to be contracting at approximately 8% annually. This persistent decline continues to exert pressure on Altria’s core business operations.
Revised Outlook Signals Continued Headwinds
Management has tightened its full-year 2025 adjusted earnings guidance to a range between $5.37 and $5.45 per share. The midpoint of this revised projection, $5.41, sits slightly below the $5.44 consensus estimate among market analysts. Company leadership has additionally cautioned investors that fourth-quarter growth is expected to decelerate significantly.
Ad
Altria Stock: Buy or Sell?! New Altria Analysis from February 7 delivers the answer:
The latest Altria figures speak for themselves: Urgent action needed for Altria investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.
Altria: Buy or sell? Read more here...
